CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm: A study comparing the role of CA 19-9 and CEA found that while serum CA 19-9 and/or CEA were elevated in 80% of cohort with invasive IPMN, CA 19-9 performed better than CEA [73].